Buy Piramal Pharma; target of Rs 171: Asit C Mehta

Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *